SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)--With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Quidel’s ...
The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription. FDA Authorizes 2 Rapid, At-Home Coronavirus Tests Imagine waking up, brushing ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rapid tests for the H1N1 pandemic flu are at least 89% accurate ...
Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...
NEW YORK (CBS.MARKETWATCH) -- Shares of diagnostic test-maker Quidel were sharply higher in afternoon trade after Pacific Growth started coverage of the stock with an "overweight" rating. Analyst Adam ...
Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...
Imagine waking up, brushing your teeth, and quickly swabbing your nose to test for the coronavirus — whether you feel sick or not. That reality just got a bit closer with an announcement from the Food ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback